Lakshmikanth Tadepally

About me
Publications
Grants
Public outreach and news

About me

2022 Feb to date: Senior Research Specialist and Team lead at Brodinlab
2021 April to date: Head of Unit, Cellular Immunomonitoring Facility -
Stockholm
2017 to 2021 March: Lab Manager and Head of Facility - Mass Cytometry,
Scilifelab, Stockholm, Sweden
2014 to date: Lab Manager and Research Coordinator - National Mass Cytometry
facility, Scilifelab, Stockholm, Sweden
2012 - 2014: Senior Scientific writer II - Oncology Scientific
Communications, GMA, Novartis, Hyderabad, India
2010 - 2012: Senior Research Fellow - Type I Diabetes, Malin Flodstrom
Tullberg's lab, CIM, Karolinska University Hospital Huddinge, Sweden
2008 - 2012: Postdoctoral researcher - NK cell biology, Klas Karre/Petter
Hoglund's labs, MTC, Karolinska Institutet, Stockholm, Sweden
2004 - 2008: PhD in Tumor Immunology, University of Catanzaro 'Magna
Graecia', Catanzaro, Italy &
Karolinska Institutet, Stockholm, Sweden

Research

Immunology, Mass Cytometry

Articles

Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2024;45(1):31
Normalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (Anifrolumab) in Patients with Type I Interferonopathies
Kretzschmar G; Paez LP; Tan Z; Wang J; Gonzalez L; Mugabo CH; Johnsson A; Chen Y; Mikes J; Lakshmikanth T; James A; Goldbach-Mansky R; Fischer M; Palmblad K; Alehashemi S; Horne A; Brodin P
Article: SCIENTIFIC REPORTS. 2024;14(1):24512
Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination.
Yalcinkaya A; Cavalli M; Aranda-Guillén M; Cederholm A; Güner A; Rietrae I; Mildner H; Behere A; Eriksson O; Gonzalez L; Mugabo CH; Johnsson A; Lakshmikanth T; Brodin P; Wadelius M; Hallberg P; Landegren N
Article: PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2024
Cytokine Profile in Children Following SARS-CoV-2 Infection: Preliminary Findings.
Buonsenso D; Camporesi A; Di Sante G; Sali M; Boza MDCP; Morello R; Valentini P; Raffaelli F; Rodriguez L; Gonzalez L; Johnsson A; Mugabo CH; Lakshmikanth T; Brodin P
Article: NATURE. 2024;633(8028):155-164
Immune system adaptation during gender-affirming testosterone treatment
Lakshmikanth T; Consiglio C; Sardh F; Forlin R; Wang J; Tan Z; Barcenilla H; Rodriguez L; Sugrue J; Noori P; Ivanchenko M; Paez LP; Gonzalez L; Mugabo CH; Johnsson A; Ryberg H; Hallgren A; Pou C; Chen Y; Mikes J; James A; Dahlqvist P; Wahlberg J; Hagelin A; Holmberg M; Degerblad M; Isaksson M; Duffy D; Kampe O; Landegren N; Brodin P
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2024;99(4):e13346
Gut bacteria at 6 months of age are associated with immune cell status in 1-year-old children
Nilsen M; Nygaard UC; Brodin P; Carlsen KCL; Fredheim C; Haugen G; Hedlin G; Jonassen CM; Jonsmoen ULA; Lakshmikanth T; Nordlund B; Olin A; Rehbinder EM; Skjerven HO; Snipen L; Staff AC; Soederhaell C; Vettukattil R; Rudi K
Article: NPJ VACCINES. 2024;9(1):42
No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines
Yalcinkaya A; Cavalli M; Cederholm A; Aranda-Guillen M; Behere A; Mildner H; Lakshmikanth T; Gonzalez L; Mugabo CH; Johnsson A; Ekwall O; Kampe O; Bensing S; Brodin P; Hallberg P; Wadelius M; Landegren N
Journal article: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2023;159:104065
Immune system adaptation during gender-affirming testosterone treatment
Consiglio C; Tadepally L; Sardh F; Forlin R; Wang J; Tan Z; Barcenilla H; Rodriguez L; Sugrue J; Noori P; Paez LP; Gonzalez L; Mugabo CH; Johnsson A; Hallgren A; Pou C; Chen Y; Mikes J; James A; Dahlqvist P; Wahlberg J; Hagelin A; Holmberg M; Degerblad M; Isaksson M; Duffy D; Kampe O; Landegren N; Brodin P
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_suppl):3110
First-in-human (FIH) phase I dose escalation study (part A) of the first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) roginolisib in patients with advanced cancer and dose confirmation in uveal melanoma (part B).
Di Giacomo AM; Santangelo F; Amato G; Simonetti E; Graham J; Lahn MMF; Di Conza G; Hammett T; Zorrilla R; Durini M; Tan Z; Tadepally L; Brodin P; Occhipinti M; Simonelli M; Carlo-Stella C; Santoro A; Spiliopoulou P; Evans TRJ; Maio M
Journal article: JOURNAL OF IMMUNOLOGY. 2023;210(1_Supplement):233.07
Immune system perturbations in patients with severe long COVID
Rodriguez L; Tan Z; Lakshmikanth T; Wang J; Barcenilla H; Gonzalez L; Mugabo C; Johnsson A; Chen Y; Mikes J; Landegren N; Runold M; Bruchfeld J; Brodin P
Article: OXFORD OPEN IMMUNOLOGY. 2023;4(1):iqad003
Achieving symptom relief in patients with myalgic encephalomyelitis by targeting the neuro-immune interface and optimizing disease tolerance.
Rodriguez L; Pou C; Lakshmikanth T; Zhang J; Mugabo CH; Wang J; Mikes J; Olin A; Chen Y; Rorbach J; Juto J-E; Li TQ; Julin P; Brodin P
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2023;43(1):136-150
Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors
Borgstrom EW; Edvinsson M; Perez LP; Norlin AC; Enoksson SL; Hansen S; Fasth A; Friman V; Kampe O; Mansson R; Estupinan HY; Qing W; Tan Z; Lakshmikanth T; Smith CIE; Brodin P; Bergman P
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2022;40(16_suppl):3107
First-in-human (FIH) phase I study of the highly selective phosphoinositide 3-kinase inhibitor delta (PI3Kδ) inhibitor IOA-244 in patients with advanced cancer: Safety, activity, pharmacokinetic (PK), and pharmacodynamic (PD) results.
Di Giacomo AM; Santangelo F; Amato G; Simonetti E; Graham J; Lahn MMF; van der Veen LA; Johnson Z; Pickering CA; Durini M; Tan Z; Tadepally L; Brodin P; Occhipinti M; Simonelli M; Carlo-Stella C; Santoro A; Spiliopoulou P; Evans TRJ; Maio M
Article: ALLERGY. 2022;77(5):1583-1595
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle
Olin A; Acevedo N; Lakshmikanth T; Chen Y; Johansson C; Alm J; Scheynius A; Brodin P
Article: CELL. 2021;184(15):3884-3898.e11
Bifidobacteria-mediated immune system imprinting early in life
Henrick BM; Rodriguez L; Lakshmikanth T; Pou C; Henckel E; Arzoomand A; Olin A; Wang J; Mikes J; Tan Z; Chen Y; Ehrlich AM; Bernhardsson AK; Mugabo CH; Ambrosiani Y; Gustafsson A; Chew S; Brown HK; Prambs J; Bohlin K; Mitchell RD; Underwood MA; Smilowitz JT; German JB; Frese SA; Brodin P
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:727300
High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glycolipids
Silva CS; Sundling C; Folkesson E; Froberg G; Nobrega C; Canto-Gomes J; Chambers BJ; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Correia-Neves M; Kallenius G
Article: SCIENTIFIC REPORTS. 2020;10(1):20425
High CD45 expression of CD8+and CD4+T cells correlates with the size of HIV-1 reservoir in blood
Petkov S; Bekele Y; Lakshmikanth T; Hejdeman B; Zazzi M; Brodin P; Chiodi F
Article: CELL. 2020;183(4):968-981.e7
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
Consiglio CR; Cotugno N; Sardh F; Pou C; Amodio D; Rodriguez L; Tan Z; Zicari S; Ruggiero A; Pascucci GR; Santilli V; Campbell T; Bryceson Y; Eriksson D; Wang J; Marchesi A; Lakshmikanth T; Campana A; Villani A; Rossi P; Landegren N; Palma P; Brodin P
Article: NATURE COMMUNICATIONS. 2020;11(1):4487
Integration of molecular profiles in a longitudinal wellness profiling cohort
Tebani A; Gummesson A; Zhong W; Koistinen IS; Lakshmikanth T; Olsson LM; Boulund F; Neiman M; Stenlund H; Hellstrom C; Karlsson MJ; Arif M; Dodig-Crnkovic T; Mardinoglu A; Lee S; Zhang C; Chen Y; Olin A; Mikes J; Danielsson H; von Feilitzen K; Jansson P-A; Angeras O; Huss M; Kjellqvist S; Odeberg J; Edfors F; Tremaroli V; Forsstrom B; Schwenk JM; Nilsson P; Moritz T; Backhed F; Engstrand L; Brodin P; Bergstrom G; Uhlen M; Fagerberg L
Article: CELL REPORTS MEDICINE. 2020;1(5):100078
Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19
Rodriguez L; Pekkarinen PT; Lakshmikanth T; Tan Z; Consiglio CR; Pou C; Chen Y; Mugabo CH; Nguyen NA; Nowlan K; Strandin T; Levanov L; Mikes J; Wang J; Kantele A; Hepojoki J; Vapalahti O; Heinonen S; Kekalainen E; Brodin P
Article: CELL REPORTS. 2020;32(3):107923
Human Immune System Variation during 1 Year
Lakshmikanth T; Muhammad SA; Olin A; Chen Y; Mikes J; Fagerberg L; Gummesson A; Bergstrom G; Uhlen M; Brodin P
Article: SCIENCE. 2019;366(6472):eaax9198
A genome-wide transcriptomic analysis of protein-coding genes in human blood cells
Uhlen M; Karlsson MJ; Zhong W; Tebani A; Pou C; Mikes J; Lakshmikanth T; Forsstrom B; Edfors F; Odeberg J; Mardinoglu A; Zhang C; von Feilitzen K; Mulder J; Sjostedt E; Hober A; Oksvold P; Zwahlen M; Ponten F; Lindskog C; Sivertsson A; Fagerberg L; Brodin P
Article: JCI INSIGHT. 2019;4(9):126492
B cell profiling in malaria reveals expansion and remodeling of CD11c⁺ B cell subsets
Sundling C; Ronnberg C; Yman V; Asghar M; Jahnmatz P; Lakshmikanth T; Chen Y; Mikes J; Forsell MN; Sonden K; Achour A; Brodin P; Persson KEM; Farnert A
Article: NATURE MEDICINE. 2019;25(4):591-596
The repertoire of maternal anti-viral antibodies in human newborns
Pou C; Nkulikiyimfura D; Henckel E; Olin A; Lakshmikanth T; Mikes J; Wang J; Chen Y; Bernhardsson AK; Gustafsson A; Bohlin K; Brodin P
Article: JCI INSIGHT. 2019;4(3):e125442
Mass cytometry identifies distinct CD4⁺ T cell clusters distinguishing HIV-1-infected patients according to antiretroviral therapy initiation
Bekele Y; Lakshmikanth T; Chen Y; Mikes J; Nasi A; Petkov S; Hejdeman B; Brodin P; Chiodi F
Article: EBIOMEDICINE. 2019;40:517-527
B cell alterations during BAFF inhibition with belimumab in SLE
Ramskold D; Parodis I; Lakshmikanth T; Sippl N; Khademi M; Chen Y; Zickert A; Mikes J; Achour A; Amara K; Piehl F; Brodin P; Gunnarsson I; Malmstrom V
Article: METHODS IN MOLECULAR BIOLOGY. 2019;1989:111-123
Automated Cell Processing for Mass Cytometry Experiments.
Mikes J; Olin A; Lakshmikanth T; Chen Y; Brodin P
Article: METHODS IN MOLECULAR BIOLOGY. 2019;1913:33-48
Systems-Level Immune Monitoring by Mass Cytometry.
Lakshmikanth T; Brodin P
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2019;89(1):e12732
Effect of CTLA4-Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositis
Tang Q; Ramskold D; Krystufkova O; Mann HF; Wick C; Dastmalchi M; Lakshmikanth T; Chen Y; Mikes J; Alexanderson H; Achour A; Brodin P; Vencovsky J; Lundberg IE; Malmstrom V
Article: CELL. 2018;174(5):1277-1292.e14
Stereotypic Immune System Development in Newborn Children
Olin A; Henckel E; Chen Y; Lakshmikanth T; Pou C; Mikes J; Gustafsson A; Bernhardsson AK; Zhang C; Bohlin K; Brodin P
Article: CELL METABOLISM. 2018;27(2):378-392.e5
Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation
Agudelo LZ; Ferreira DMS; Cervenka I; Bryzgalova G; Dadvar S; Jannig PR; Pettersson-Klein AT; Lakshmikanth T; Sustarsic EG; Porsmyr-Palmertz M; Correia JC; Izadi M; Martinez-Redondo V; Ueland PM; Midttun O; Gerhart-Hines Z; Brodin P; Pereira T; Berggren P-O; Ruas JL
Article: FRONTIERS IN MOLECULAR BIOSCIENCES. 2018;5:81
Continuous Immune Cell Differentiation Inferred From Single-Cell Measurements Following Allogeneic Stem Cell Transplantation
Chen Y; Lakshmikanth T; Olin A; Mikes J; Remberger M; Brodin P
Article: CELL REPORTS. 2017;20(9):2238-2250
Mass Cytometry and Topological Data Analysis Reveal Immune Parameters Associated with Complications after Allogeneic Stem Cell Transplantation
Lakshmikanth T; Olin A; Chen Y; Mikes J; Fredlund E; Remberger M; Omazic B; Brodin P
Article: FRONTIERS IN IMMUNOLOGY. 2017;8:1130
Mass Cytometry Identifies Distinct Lung CD4⁺ T Cell Patterns in Lofgren's Syndrome and Non-Lofgren's Syndrome Sarcoidosis
Kaiser Y; Lakshmikanth T; Chen Y; Mikes J; Eklund A; Brodin P; Achour A; Grunewald J
Article: FRONTIERS IN IMMUNOLOGY. 2017;8:717
Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease
Stikvoort A; Chen Y; Radestad E; Torlen J; Lakshmikanth T; Bjorklund A; Mikes J; Achour A; Gertow J; Sundberg B; Remberger M; Sundin M; Mattsson J; Brodin P; Uhlin M
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46(7):1758-1769
In vivo engineering of mobilized stem cell grafts with the immunomodulatory drug FTY720 for allogeneic transplantation
Lakshmikanth T; Heuts F; Muvva SSVJR; Wallin RPA; Persson A-K; Fauriat C; Applequist SE; Ljunggren H-G; Hoglund P; Karre K; Svensson M; Juarez JG
Article: CANCER IMMUNOLOGY RESEARCH. 2016;4(2):113-123
Retuning of Mouse NK Cells after Interference with MHC Class I Sensing Adjusts Self-Tolerance but Preserves Anticancer Response
Wagner AK; Wickstrom SL; Tallerico R; Salam S; Lakshmikanth T; Brauner H; Hoglund P; Carbone E; Johansson MH; Karre K
Article: DIABETOLOGIA. 2015;58(2):346-354
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models
Larsson PG; Lakshmikanth T; Laitinen OH; Utorova R; Jacobson S; Oikarinen M; Domsgen E; Koivunen MRL; Chaux P; Devard N; Lecouturier V; Almond J; Knip M; Hyoty H; Flodstrom-Tullberg M
Article: PLOS ONE. 2014;9(12):e111758
Mechanical Stress Downregulates MHC Class I Expression on Human Cancer Cell Membrane
La Rocca R; Tallerico R; Hassan AT; Das G; Tadepally L; Matteucci M; Liberale C; Mesuraca M; Scumaci D; Gentile F; Cojoc G; Perozziello G; Ammendolia A; Gallo A; Karre K; Cuda G; Candeloro P; Di Fabrizio E; Carbone E
Article: DIABETOLOGIA. 2013;56(4):867-874
Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice
Larsson PG; Lakshmikanth T; Svedin E; King C; Flodstrom-Tullberg M
Article: JOURNAL OF IMMUNOLOGY. 2012;188(5):2218-2226
Skewing of the NK Cell Repertoire by MHC Class I via Quantitatively Controlled Enrichment and Contraction of Specific Ly49 Subsets
Brodin P; Lakshmikanth T; Karre K; Hoglund P
Article: CELL CYCLE. 2011;10(19):3346-3358
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2
Li H; Lakshmikanth T; Garofalo C; Enge M; Spinnler C; Anichini A; Szekely L; Karre K; Carbone E; Selivanova G
Article: PLOS ONE. 2010;5(10):e13174
Natural Killer Cell Tolerance Persists Despite Significant Reduction of Self MHC Class I on Normal Target Cells in Mice
Brodin P; Lakshmikanth T; Mehr R; Johansson MH; Duru AD; Achour A; Salmon-Divon M; Karre K; Hoglund P; Johansson S
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2010;40(3):813-823
In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: Maintained tolerance to normal cells even in the presence of IL-2
Vahlne G; Lindholm K; Meier A; Wickstrom S; Lakshmikanth T; Brennan F; Wilken M; Nielsen R; Romagne F; Wagtmann NR; Karre K; Johansson MH
Article: JOURNAL OF BIOMEDICAL OPTICS. 2010;15(2):027007
Monitoring human leukocyte antigen class I molecules by micro-Raman spectroscopy at single-cell level
Das G; La Rocca R; Lakshmikanth T; Gentile F; Tallerico R; Zambetti LP; Devitt J; Candeloro P; De Angelis F; Carbone E; Di Fabrizio E
Article: JOURNAL OF CLINICAL INVESTIGATION. 2009;119(5):1251-1263
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
Lakshmikanth T; Burke S; Ali TH; Kimpfler S; Ursini F; Ruggeri L; Capanni M; Umansky V; Paschen A; Sucker A; Pende D; Groh V; Biassoni R; Hoglund P; Kato M; Shibuya K; Schadendorf D; Anichini A; Ferrone S; Velardi A; Karre K; Shibuya A; Carbone E; Colucci F
Article: JOURNAL OF IMMUNOLOGY. 2009;182(8):4529-4537
Early Hematopoietic Zinc Finger Protein Prevents Tumor Cell Recognition by Natural Killer Cells
La Rocca R; Fulciniti M; Lakshmikanth T; Mesuraca M; Ali TH; Mazzei V; Amodio N; Catalano L; Rotoli B; Ouerfelli O; Grieco M; Gulletta E; Bond HM; Morrone G; Ferrone S; Carbone E
Article: BLOOD. 2009;113(11):2434-2441
The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells
Brodin P; Lakshmikanth T; Johansson S; Karre K; Hoglund P
Article: JOURNAL OF IMMUNOLOGY. 2009;182(3):1460-1468
Distinct and Overlapping Patterns of Cytokine Regulation of Thymic and Bone Marrow-Derived NK Cell Development
Cheng M; Charoudeh HN; Brodin P; Tang Y; Lakshmikanth T; Hoglund P; Jacobsen SEW; Sitnicka E
Article: NATIONAL ACADEMY SCIENCE LETTERS-INDIA. 2005;28(9-10):353-355
Detection of haemocyanin in native PAGE gels
Krupanidhi S; Lakshmikanth T
Show more

All other publications

Corrigendum: NATURE. 2024;634(8033):e5
Immune system adaptation during gender-affirming testosterone treatment (vol 633, pg 155, 2024)
Lakshmikanth T; Consiglio C; Sardh F; Forlin R; Wang J; Tan Z; Barcenilla H; Rodriguez L; Sugrue J; Noori P; Ivanchenko M; Paez LP; Gonzalez L; Mugabo CH; Johnsson A; Ryberg H; Hallgren A; Pou C; Chen Y; Mikes J; James A; Dahlqvist P; Wahlberg J; Hagelin A; Holmberg M; Degerblad M; Isaksson M; Duffy D; Kampe O; Landegren N; Brodin P
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)
First-in-human (FIH) phase I dose escalation study (part A) of the first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ) roginolisib in patients with advanced cancer and dose confirmation in uveal melanoma (part B).
Di Giacomo AM; Santangelo F; Amato G; Simonetti E; Graham J; Lahn MMF; Di Conza G; Hammett T; Zorrilla R; Durini M; Tan Z; Tadepally L; Brodin P; Occhipinti M; Simonelli M; Carlo-Stella C; Santoro A; Spiliopoulou P; Evans TRJ; Maio M
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2022;40(16)
First-in-human (FIH) phase I study of the highly selective phosphoinositide 3-kinase inhibitor delta (PI3Kδ) inhibitor IOA-244 in patients with advanced cancer: Safety, activity, pharmacokinetic (PK), and pharmacodynamic (PD) results.
Di Giacomo AM; Santangelo F; Amato G; Simonetti E; Graham J; Lahn MMF; Van der Veen LA; Johnson Z; Pickering CA; Durini M; Tan Z; Tadepally L; Brodin P; Occhipinti M; Simonelli M; Carlo-Stella C; Santoro A; Spiliopoulou P; Evans TRJ; Maio M
Preprint: BIORXIV. 2021
Stimulation with mycobacterial glycolipids and PPD reveals different innate immune response profiles in active and latent TB
Silva C; Sundling C; Folkeson E; Fröberg G; Nobrega C; Canto-Gomes J; Chambers B; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Correia-Neves M; Källenius G
Preprint: BIORXIV. 2020
Bifidobacteria-mediated immune system imprinting early in life
Henrick B; Rodriguez L; Lakshmikanth T; Pou C; Henckel E; Olin A; Wang J; Mikes J; Tan Z; Chen Y; Ehrlich A; Bernhardsson AK; Mugabo CH; Ambrosiani Y; Gustafsson A; Chew S; Brown H; Prambs J; Bohlin K; Mitchell R; Underwood M; Smilowitz J; German B; Frese S; Brodin P
Preprint: BIORXIV. 2020
Single-cell classification using learned cell phenotypes
Chen Y; Lakshmikanth T; Mikes J; Brodin P
Editorial comment: ONCOIMMUNOLOGY. 2012;1(4):541-543
A novel facet of tumor suppression by p53 Induction of tumor immunogenicity
Li H; Lakshmikanth T; Carbone E; Selivanova G
Review: TRENDS IN IMMUNOLOGY. 2010;31(9):339-345
New views on natural killer cell-based immunotherapy for melanoma treatment
Burke S; Lakshmikanth T; Colucci F; Carbone E
Published conference paper: MICROELECTRONIC ENGINEERING. 2007;84(5-8):1729-1732
Preliminary study of micromechanical stress delivery for cell biology studies
Matteucci M; Lakshmikanth T; Shibu K; De Angelis F; Schadendorf D; Venuta S; Carbone E; Di Fabrizio E

Grants

Identifying a transcriptional signature of missing self rejection by NK cells in vivo
Swedish Research Council
1 July 2009 - 31 July 2010

About me

Research

Articles

All other publications

Grants

News from KI

Events from KI